Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 18:26:42 UTC
Update Date2021-09-26 23:13:51 UTC
HMDB IDHMDB0257458
Secondary Accession NumbersNone
Metabolite Identification
Common NameSalicylamide glucuronide
Description3,4,5-trihydroxy-6-[2-(C-hydroxycarbonimidoyl)phenoxy]oxane-2-carboxylic acid belongs to the class of organic compounds known as phenolic glycosides. These are organic compounds containing a phenolic structure attached to a glycosyl moiety. Some examples of phenolic structures include lignans, and flavonoids. Among the sugar units found in natural glycosides are D-glucose, L-Fructose, and L rhamnose. Based on a literature review very few articles have been published on 3,4,5-trihydroxy-6-[2-(C-hydroxycarbonimidoyl)phenoxy]oxane-2-carboxylic acid. This compound has been identified in human blood as reported by (PMID: 31557052 ). Salicylamide glucuronide is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Salicylamide glucuronide is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
3,4,5-Trihydroxy-6-[2-(C-hydroxycarbonimidoyl)phenoxy]oxane-2-carboxylateGenerator
Chemical FormulaC13H15NO8
Average Molecular Weight313.262
Monoisotopic Molecular Weight313.079766447
IUPAC Name6-(2-carbamoylphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid
Traditional Name6-(2-carbamoylphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid
CAS Registry NumberNot Available
SMILES
NC(=O)C1=CC=CC=C1OC1OC(C(O)C(O)C1O)C(O)=O
InChI Identifier
InChI=1S/C13H15NO8/c14-11(18)5-3-1-2-4-6(5)21-13-9(17)7(15)8(16)10(22-13)12(19)20/h1-4,7-10,13,15-17H,(H2,14,18)(H,19,20)
InChI KeyAEMUKQHDNNVAES-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as phenolic glycosides. These are organic compounds containing a phenolic structure attached to a glycosyl moiety. Some examples of phenolic structures include lignans, and flavonoids. Among the sugar units found in natural glycosides are D-glucose, L-Fructose, and L rhamnose.
KingdomOrganic compounds
Super ClassOrganic oxygen compounds
ClassOrganooxygen compounds
Sub ClassCarbohydrates and carbohydrate conjugates
Direct ParentPhenolic glycosides
Alternative Parents
Substituents
  • Phenolic glycoside
  • 1-o-glucuronide
  • O-glucuronide
  • Glucuronic acid or derivatives
  • O-glycosyl compound
  • Phenoxy compound
  • Phenol ether
  • Beta-hydroxy acid
  • Monocyclic benzene moiety
  • Hydroxy acid
  • Monosaccharide
  • Benzenoid
  • Pyran
  • Oxane
  • Secondary alcohol
  • Acetal
  • Carboximidic acid
  • Carboximidic acid derivative
  • Carboxylic acid derivative
  • Carboxylic acid
  • Monocarboxylic acid or derivatives
  • Oxacycle
  • Organoheterocyclic compound
  • Polyol
  • Organopnictogen compound
  • Organic oxide
  • Hydrocarbon derivative
  • Carbonyl group
  • Alcohol
  • Organic nitrogen compound
  • Organonitrogen compound
  • Aromatic heteromonocyclic compound
Molecular FrameworkAromatic heteromonocyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP-1.6ALOGPS
logP-1.4ChemAxon
logS-1.3ALOGPS
pKa (Strongest Acidic)3.14ChemAxon
pKa (Strongest Basic)-0.96ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count8ChemAxon
Hydrogen Donor Count5ChemAxon
Polar Surface Area159.54 ŲChemAxon
Rotatable Bond Count4ChemAxon
Refractivity69.13 m³·mol⁻¹ChemAxon
Polarizability28.47 ųChemAxon
Number of Rings2ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+165.64730932474
DeepCCS[M-H]-163.28930932474
DeepCCS[M-2H]-196.17630932474
DeepCCS[M+Na]+171.74130932474
AllCCS[M+H]+171.332859911
AllCCS[M+H-H2O]+168.132859911
AllCCS[M+NH4]+174.432859911
AllCCS[M+Na]+175.232859911
AllCCS[M-H]-166.432859911
AllCCS[M+Na-2H]-166.232859911
AllCCS[M+HCOO]-166.032859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
Salicylamide glucuronideNC(=O)C1=CC=CC=C1OC1OC(C(O)C(O)C1O)C(O)=O3745.9Standard polar33892256
Salicylamide glucuronideNC(=O)C1=CC=CC=C1OC1OC(C(O)C(O)C1O)C(O)=O2860.9Standard non polar33892256
Salicylamide glucuronideNC(=O)C1=CC=CC=C1OC1OC(C(O)C(O)C1O)C(O)=O3016.4Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Salicylamide glucuronide,5TMS,isomer #1C[Si](C)(C)NC(=O)C1=CC=CC=C1OC1OC(C(=O)O[Si](C)(C)C)C(O[Si](C)(C)C)C(O[Si](C)(C)C)C1O[Si](C)(C)C2854.5Semi standard non polar33892256
Salicylamide glucuronide,5TMS,isomer #1C[Si](C)(C)NC(=O)C1=CC=CC=C1OC1OC(C(=O)O[Si](C)(C)C)C(O[Si](C)(C)C)C(O[Si](C)(C)C)C1O[Si](C)(C)C2722.1Standard non polar33892256
Salicylamide glucuronide,5TMS,isomer #1C[Si](C)(C)NC(=O)C1=CC=CC=C1OC1OC(C(=O)O[Si](C)(C)C)C(O[Si](C)(C)C)C(O[Si](C)(C)C)C1O[Si](C)(C)C3013.3Standard polar33892256
Salicylamide glucuronide,5TMS,isomer #2C[Si](C)(C)OC(=O)C1OC(OC2=CC=CC=C2C(=O)N([Si](C)(C)C)[Si](C)(C)C)C(O[Si](C)(C)C)C(O)C1O[Si](C)(C)C2887.1Semi standard non polar33892256
Salicylamide glucuronide,5TMS,isomer #2C[Si](C)(C)OC(=O)C1OC(OC2=CC=CC=C2C(=O)N([Si](C)(C)C)[Si](C)(C)C)C(O[Si](C)(C)C)C(O)C1O[Si](C)(C)C2806.9Standard non polar33892256
Salicylamide glucuronide,5TMS,isomer #2C[Si](C)(C)OC(=O)C1OC(OC2=CC=CC=C2C(=O)N([Si](C)(C)C)[Si](C)(C)C)C(O[Si](C)(C)C)C(O)C1O[Si](C)(C)C3225.8Standard polar33892256
Salicylamide glucuronide,5TMS,isomer #3C[Si](C)(C)OC(=O)C1OC(OC2=CC=CC=C2C(=O)N([Si](C)(C)C)[Si](C)(C)C)C(O)C(O[Si](C)(C)C)C1O[Si](C)(C)C2861.4Semi standard non polar33892256
Salicylamide glucuronide,5TMS,isomer #3C[Si](C)(C)OC(=O)C1OC(OC2=CC=CC=C2C(=O)N([Si](C)(C)C)[Si](C)(C)C)C(O)C(O[Si](C)(C)C)C1O[Si](C)(C)C2742.7Standard non polar33892256
Salicylamide glucuronide,5TMS,isomer #3C[Si](C)(C)OC(=O)C1OC(OC2=CC=CC=C2C(=O)N([Si](C)(C)C)[Si](C)(C)C)C(O)C(O[Si](C)(C)C)C1O[Si](C)(C)C3184.2Standard polar33892256
Salicylamide glucuronide,5TMS,isomer #4C[Si](C)(C)OC1C(OC2=CC=CC=C2C(=O)N([Si](C)(C)C)[Si](C)(C)C)OC(C(=O)O)C(O[Si](C)(C)C)C1O[Si](C)(C)C2872.8Semi standard non polar33892256
Salicylamide glucuronide,5TMS,isomer #4C[Si](C)(C)OC1C(OC2=CC=CC=C2C(=O)N([Si](C)(C)C)[Si](C)(C)C)OC(C(=O)O)C(O[Si](C)(C)C)C1O[Si](C)(C)C2716.1Standard non polar33892256
Salicylamide glucuronide,5TMS,isomer #4C[Si](C)(C)OC1C(OC2=CC=CC=C2C(=O)N([Si](C)(C)C)[Si](C)(C)C)OC(C(=O)O)C(O[Si](C)(C)C)C1O[Si](C)(C)C3153.7Standard polar33892256
Salicylamide glucuronide,5TMS,isomer #5C[Si](C)(C)OC(=O)C1OC(OC2=CC=CC=C2C(=O)N([Si](C)(C)C)[Si](C)(C)C)C(O[Si](C)(C)C)C(O[Si](C)(C)C)C1O2863.1Semi standard non polar33892256
Salicylamide glucuronide,5TMS,isomer #5C[Si](C)(C)OC(=O)C1OC(OC2=CC=CC=C2C(=O)N([Si](C)(C)C)[Si](C)(C)C)C(O[Si](C)(C)C)C(O[Si](C)(C)C)C1O2742.6Standard non polar33892256
Salicylamide glucuronide,5TMS,isomer #5C[Si](C)(C)OC(=O)C1OC(OC2=CC=CC=C2C(=O)N([Si](C)(C)C)[Si](C)(C)C)C(O[Si](C)(C)C)C(O[Si](C)(C)C)C1O3191.6Standard polar33892256
Salicylamide glucuronide,6TMS,isomer #1C[Si](C)(C)OC(=O)C1OC(OC2=CC=CC=C2C(=O)N([Si](C)(C)C)[Si](C)(C)C)C(O[Si](C)(C)C)C(O[Si](C)(C)C)C1O[Si](C)(C)C2903.7Semi standard non polar33892256
Salicylamide glucuronide,6TMS,isomer #1C[Si](C)(C)OC(=O)C1OC(OC2=CC=CC=C2C(=O)N([Si](C)(C)C)[Si](C)(C)C)C(O[Si](C)(C)C)C(O[Si](C)(C)C)C1O[Si](C)(C)C2729.4Standard non polar33892256
Salicylamide glucuronide,6TMS,isomer #1C[Si](C)(C)OC(=O)C1OC(OC2=CC=CC=C2C(=O)N([Si](C)(C)C)[Si](C)(C)C)C(O[Si](C)(C)C)C(O[Si](C)(C)C)C1O[Si](C)(C)C2948.5Standard polar33892256
Salicylamide glucuronide,5TBDMS,isomer #1CC(C)(C)[Si](C)(C)NC(=O)C1=CC=CC=C1OC1OC(C(=O)O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C1O[Si](C)(C)C(C)(C)C3767.5Semi standard non polar33892256
Salicylamide glucuronide,5TBDMS,isomer #1CC(C)(C)[Si](C)(C)NC(=O)C1=CC=CC=C1OC1OC(C(=O)O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C1O[Si](C)(C)C(C)(C)C3578.0Standard non polar33892256
Salicylamide glucuronide,5TBDMS,isomer #1CC(C)(C)[Si](C)(C)NC(=O)C1=CC=CC=C1OC1OC(C(=O)O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C1O[Si](C)(C)C(C)(C)C3467.2Standard polar33892256
Salicylamide glucuronide,5TBDMS,isomer #2CC(C)(C)[Si](C)(C)OC(=O)C1OC(OC2=CC=CC=C2C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C(O)C1O[Si](C)(C)C(C)(C)C3823.5Semi standard non polar33892256
Salicylamide glucuronide,5TBDMS,isomer #2CC(C)(C)[Si](C)(C)OC(=O)C1OC(OC2=CC=CC=C2C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C(O)C1O[Si](C)(C)C(C)(C)C3692.9Standard non polar33892256
Salicylamide glucuronide,5TBDMS,isomer #2CC(C)(C)[Si](C)(C)OC(=O)C1OC(OC2=CC=CC=C2C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C(O)C1O[Si](C)(C)C(C)(C)C3573.2Standard polar33892256
Salicylamide glucuronide,5TBDMS,isomer #3CC(C)(C)[Si](C)(C)OC(=O)C1OC(OC2=CC=CC=C2C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(O)C(O[Si](C)(C)C(C)(C)C)C1O[Si](C)(C)C(C)(C)C3785.5Semi standard non polar33892256
Salicylamide glucuronide,5TBDMS,isomer #3CC(C)(C)[Si](C)(C)OC(=O)C1OC(OC2=CC=CC=C2C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(O)C(O[Si](C)(C)C(C)(C)C)C1O[Si](C)(C)C(C)(C)C3625.0Standard non polar33892256
Salicylamide glucuronide,5TBDMS,isomer #3CC(C)(C)[Si](C)(C)OC(=O)C1OC(OC2=CC=CC=C2C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(O)C(O[Si](C)(C)C(C)(C)C)C1O[Si](C)(C)C(C)(C)C3541.6Standard polar33892256
Salicylamide glucuronide,5TBDMS,isomer #4CC(C)(C)[Si](C)(C)OC1C(OC2=CC=CC=C2C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)OC(C(=O)O)C(O[Si](C)(C)C(C)(C)C)C1O[Si](C)(C)C(C)(C)C3819.2Semi standard non polar33892256
Salicylamide glucuronide,5TBDMS,isomer #4CC(C)(C)[Si](C)(C)OC1C(OC2=CC=CC=C2C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)OC(C(=O)O)C(O[Si](C)(C)C(C)(C)C)C1O[Si](C)(C)C(C)(C)C3584.8Standard non polar33892256
Salicylamide glucuronide,5TBDMS,isomer #4CC(C)(C)[Si](C)(C)OC1C(OC2=CC=CC=C2C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)OC(C(=O)O)C(O[Si](C)(C)C(C)(C)C)C1O[Si](C)(C)C(C)(C)C3527.5Standard polar33892256
Salicylamide glucuronide,5TBDMS,isomer #5CC(C)(C)[Si](C)(C)OC(=O)C1OC(OC2=CC=CC=C2C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C1O3783.7Semi standard non polar33892256
Salicylamide glucuronide,5TBDMS,isomer #5CC(C)(C)[Si](C)(C)OC(=O)C1OC(OC2=CC=CC=C2C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C1O3621.0Standard non polar33892256
Salicylamide glucuronide,5TBDMS,isomer #5CC(C)(C)[Si](C)(C)OC(=O)C1OC(OC2=CC=CC=C2C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)C1O3546.6Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Salicylamide glucuronide GC-MS (Non-derivatized) - 70eV, Positivesplash10-054k-9470000000-eadd100d212267335c112021-09-24Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Salicylamide glucuronide GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Salicylamide glucuronide GC-MS (TMS_1_1) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Salicylamide glucuronide GC-MS (TMS_1_2) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Salicylamide glucuronide GC-MS (TMS_1_3) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Salicylamide glucuronide GC-MS (TMS_1_4) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Salicylamide glucuronide GC-MS (TMS_1_5) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Salicylamide glucuronide GC-MS (TMS_2_1) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Salicylamide glucuronide GC-MS (TMS_2_2) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Salicylamide glucuronide GC-MS (TMS_2_3) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Salicylamide glucuronide GC-MS (TMS_2_4) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Salicylamide glucuronide GC-MS (TMS_2_5) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Salicylamide glucuronide GC-MS (TMS_2_6) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Salicylamide glucuronide GC-MS (TMS_2_7) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Salicylamide glucuronide GC-MS (TMS_2_8) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Salicylamide glucuronide GC-MS (TMS_2_9) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Salicylamide glucuronide GC-MS (TMS_2_10) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Salicylamide glucuronide GC-MS (TMS_2_11) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Salicylamide glucuronide GC-MS (TMS_3_1) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Salicylamide glucuronide GC-MS (TMS_3_2) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Salicylamide glucuronide GC-MS (TMS_3_3) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Salicylamide glucuronide GC-MS (TMS_3_4) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Salicylamide glucuronide GC-MS (TMS_3_5) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Salicylamide glucuronide GC-MS (TMS_3_6) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Salicylamide glucuronide GC-MS (TMS_3_7) - 70eV, PositiveNot Available2021-11-05Wishart LabView Spectrum

NMR Spectra

Spectrum TypeDescriptionDeposition DateSourceView
Predicted 1D NMR13C NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID14267913
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem CompoundNot Available
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]